Efficacy and Safety of Gemcitabine-Fluorouracil Combination Therapy in the Management of Advanced Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and Safety of Gemcitabine-Fluorouracil Combination Therapy in the Management of Advanced Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials
Authors
Keywords
Meta-analysis, Toxicity, Diarrhea, Drug therapy, Neutropenia, Thrombocytopenia, Pancreatic cancer, Randomized controlled trials
Journal
PLoS One
Volume 9, Issue 8, Pages e104346
Publisher
Public Library of Science (PLoS)
Online
2014-08-06
DOI
10.1371/journal.pone.0104346
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
- (2013) Hideki Ueno et al. JOURNAL OF CLINICAL ONCOLOGY
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gemcitabine Plus Capecitabine in Unselected Patients With Advanced Pancreatic Cancer
- (2013) Richard A. Hubner et al. PANCREAS
- A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study
- (2012) Y Nakai et al. BRITISH JOURNAL OF CANCER
- Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer Research Organization PC-01 study)
- (2012) Masato Ozaka et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Role of gemcitabine-based combination therapy in the management of advanced pancreatic cancer: A meta-analysis of randomised trials
- (2012) Domenico Ciliberto et al. EUROPEAN JOURNAL OF CANCER
- Impact of FOLFIRINOX Compared With Gemcitabine on Quality of Life in Patients With Metastatic Pancreatic Cancer: Results From the PRODIGE 4/ACCORD 11 Randomized Trial
- (2012) Sophie Gourgou-Bourgade et al. JOURNAL OF CLINICAL ONCOLOGY
- Does gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer?
- (2012) Chen Sun WORLD JOURNAL OF GASTROENTEROLOGY
- A Phase II Trial of Gemcitabine plus Capecitabine for Patients with Advanced Pancreatic Cancer
- (2012) Jong Gwon Choi et al. Cancer Research and Treatment
- A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma
- (2011) Jing Hu et al. Journal of Hematology & Oncology
- Gemcitabine-based Cytotoxic Doublets Chemotherapy for Advanced Pancreatic Cancer: Updated Subgroup Meta-analyses of Overall Survival
- (2010) D. r. Xie et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Capecitabine-based chemotherapy for metastatic colorectal cancer
- (2010) Wei Ling et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- S-1: a promising new oral fluoropyrimidine derivative
- (2009) Muhammad Wasif Saif et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
- (2009) David Cunningham et al. JOURNAL OF CLINICAL ONCOLOGY
- Long term survivors with metastatic pancreatic adenocarcinoma treated with gemcitabine: a retrospective analysis
- (2009) Bernardo HL Goulart et al. Journal of Hematology & Oncology
- Gemcitabine versus Gemcitabine Combined with Cisplatin Treatment Locally Advanced or Metastatic Pancreatic Cancer: A Retrospective Analysis
- (2009) Jae-Hyuk Choi et al. Cancer Research and Treatment
- Development History and Concept of an Oral Anticancer Agent S-1 (TS-1(R)): Its Clinical Usefulness and Future Vistas
- (2008) T. Shirasaka JAPANESE JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started